• ქართული
  • English
  • Takeda CEO confident of investor backing for $62 billion Shire deal

    The boss of Japan’s Takeda Pharmaceutical said on Monday he was confident of securing investor backing for its $62 billion acquisition of London-listed Shire , despite some shareholders’ fears about the resulting debt burden.

    Market Quotes by TradingView